The FDA granted orphan drug designation to MVdeltaC, a measles virus-based immunotherapy, for pleural mesothelioma, supporting its future growth.The U.S. Meals and Drug...
From left: Katherine Mast Hagemann, B.S.N., RN, and Dr. Andrew KuykendallThe present atmosphere in oncology (and medication on the whole) incentivizes hurried, impersonal...
Recap of each FDA approval introduced by the regulatory company within the month of Could 2025, spanning varied most cancers sorts.Throughout the month...
